Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper
- PMID: 25938853
- PMCID: PMC4467583
- DOI: 10.1097/MPA.0000000000000369
Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper
Abstract
Innovation leading to significant advances in research and subsequent translation to clinical practice is urgently necessary in early detection of sporadic pancreatic cancer. Addressing this need, the Early Detection of Sporadic Pancreatic Cancer Summit Conference was conducted by Kenner Family Research Fund in conjunction with the 2014 American Pancreatic Association and Japan Pancreas Society Meeting. International interdisciplinary scientific representatives engaged in strategic facilitated conversations based on distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. Ideas generated from the summit have led to the development of a Strategic Map for Innovation built upon 3 components: formation of an international collaborative effort, design of an actionable strategic plan, and implementation of operational standards, research priorities, and first-phase initiatives. Through invested and committed efforts of leading researchers and institutions, philanthropic partners, government agencies, and supportive business entities, this endeavor will change the future of the field and consequently the survival rate of those diagnosed with pancreatic cancer.
Figures
References
-
- Trends in SEER incidence and U.S. mortality using the Joinpoint Regression Program, 1975–2011 with up to five Joinpoints, 1992–2011 with up to three Joinpoints, both sexes by race/ethnicity. Available at: http://seer.cancer.gov/csr/1975_2011/results_merged/sect_22_pancreas.pdf.... Accessed April 1, 2015.
-
- National Cancer Institute: Surveillance, Epidemiology, and End Results Program (SEER): turning cancer data into discovery. Available at: http://seer.cancer.gov/faststats/. Accessed April 1, 2015.
-
- Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014; 74: 2913– 2921. - PubMed
